Prediction of Human Pharmacokinetics Using Physiologically Based Modeling: A Retrospective Analysis of 26 Clinically Tested Drugs
Top Cited Papers
- 1 October 2007
- journal article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 35 (10) , 1766-1780
- https://doi.org/10.1124/dmd.107.015644
Abstract
The aim of this study was to evaluate different physiologically based modeling strategies for the prediction of human pharmacokinetics. Plasma profiles after intravenous and oral dosing were simulated for 26 clinically tested drugs. Two mechanism-based predictions of human tissue-to-plasma partitioning (Ptp) from physicochemical input (method Vd1) were evaluated for their ability to describe human volume of distribution at steady state (Vss). This method was compared with a strategy that combined predicted and experimentally determined in vivo rat Ptp data (method Vd2). Best Vss predictions were obtained using method Vd2, providing that rat Ptp input was corrected for interspecies differences in plasma protein binding (84% within 2-fold). Vss predictions from physicochemical input alone were poor (32% within 2-fold). Total body clearance (CL) was predicted as the sum of scaled rat renal clearance and hepatic clearance projected from in vitro metabolism data. Best CL predictions were obtained by disregarding both blood and microsomal or hepatocyte binding (method CL2, 74% within 2-fold), whereas strong bias was seen using both blood and microsomal or hepatocyte binding (method CL1, 53% within 2-fold). The physiologically based pharmacokinetics (PBPK) model, which combined methods Vd2 and CL2 yielded the most accurate predictions of in vivo terminal half-life (69% within 2-fold). The Gastroplus advanced compartmental absorption and transit model was used to construct an absorption-disposition model and provided accurate predictions of area under the plasma concentration-time profile, oral apparent volume of distribution, and maximum plasma concentration after oral dosing, with 74%, 70%, and 65% within 2-fold, respectively. This evaluation demonstrates that PBPK models can lead to reasonable predictions of human pharmacokinetics.Keywords
This publication has 36 references indexed in Scilit:
- The Prediction of Drug Metabolism, Tissue Distribution, and Bioavailability of 50 Structurally Diverse Compounds in Rat Using Mechanism-Based Absorption, Distribution, and Metabolism Prediction ToolsDrug Metabolism and Disposition, 2007
- DIRECT DETERMINATION OF UNBOUND INTRINSIC DRUG CLEARANCE IN THE MICROSOMAL STABILITY ASSAYDrug Metabolism and Disposition, 2005
- Comparison of the Use of Liver Models for Predicting Drug Clearance Using in Vitro Kinetic Data from Hepatic Microsomes and Isolated HepatocytesPharmaceutical Research, 2004
- The Influence of Nonspecific Microsomal Binding on Apparent Intrinsic Clearance, and Its Prediction from Physicochemical PropertiesDrug Metabolism and Disposition, 2002
- Prediction of the volume of distribution of a drug: which tissue-plasma partition coefficients are needed?Journal of Pharmacy and Pharmacology, 2002
- Predicting the impact of physiological and biochemical processes on oral drug bioavailabilityAdvanced Drug Delivery Reviews, 2001
- Measurement of interstitial albumin in human skeletal muscle and adipose tissue by open-flow microperfusionAmerican Journal of Physiology-Endocrinology and Metabolism, 2000
- Prediction of Hepatic Clearance from Microsomes, Hepatocytes, and Liver SlicesDrug Metabolism Reviews, 1997
- Utility of in vitro drug metabolism data in predicting in vivo metabolic clearanceBiochemical Pharmacology, 1994
- Physiological pharmacokineticsBulletin of Mathematical Biology, 1986